Abstract:Lnc00113 is highly expressed in triple‐negative breast cancer. Lnc00113 can regulate NOB1 expression by competitively adsorbing NOB1 mRNA with miR‐107 and promoting tumor progression through the NOB‐1/MAPK axis. Background Triple‐negative breast cancer (TNBC) represents the most aggressive form of breast cancer. While the involvement of long non‐coding RNA (lncRNA) in the progression of TNBC has been demonstrated, the role of Lnc00113 in TNBC remains unexplored. We aimed to explore the function of Lnc00113 in TNBC. Methods Expression levels and the clinical significance of Lnc00113 were assessed in The Cancer Genome Atlas (TCGA) database. The expression levels of Lnc00113 in TNBC tissues and cell lines were examined using qRT‐PCR (quantitative Real‐Time Polymerase chain reaction). The proliferation, apoptosis and invasion abilities were evaluated using CCK‐8 (Cell Counting Kit‐8), EdU (5‐Ethynyl‐2'‐deoxyuridine), apoptosis and transwell assays following Lnc00113 knockdown/overexpression. Dual‐luciferase and fluorescence in situ hybridization assays were employed to detect the correlation between Lnc00113, miR‐107 and Nin‐one binding protein (NOB‐1). Results We identified significant upregulation of Lnc00113 in TNBC tissues and cell lines, with high Lnc00113 expression correlating with advanced pathological staging and poorer prognosis in the TCGA database. Functional assessments through knockdown/overexpression experiments revealed that Lnc00113 promoted TNBC cell proliferation, apoptosis and invasion. Fluorescence in situ hybridization experiments showed cytoplasmic localization of both Lnc00113 and NOB‐1. Dual‐luciferase assays demonstrated direct binding between Lnc00113 and miR‐107, while miR‐107 directly interacted with NOB‐1. Mechanistically, our findings indicated that Lnc00113 promotes TNBC progression through the miR‐107/NOB‐1/MAPK signaling axis. Conclusion Lnc00113 emerges as a potential driver of TNBC growth and progression through modulation of the NOB‐1/MAPK signaling axis, providing insights into diagnostic biomarkers and therapeutic targets for TNBC.

Lentivirus-Mediated Knockdown of NOB1 Suppresses the Proliferation of Colon Cancer Cells

Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo.

Silencing NOB1 Can Affect Cell Proliferation and Apoptosis Via the C-Jun N-Terminal Kinase Pathway in Colorectal Cancer

Sirna Mediated Silencing of NIN1/RPN12 Binding Protein 1 Homolog Inhibits Proliferation and Growth of Breast Cancer Cells.

Knockdown of NOB1 Expression by RNAi Inhibits Cellular Proliferation and Migration in Human Gliomas.

Inhibition of NOB1 by Microrna-330-5p Overexpression Represses Cell Growth of Non-Small Cell Lung Cancer.

MicroRNA-326 Functions As a Tumor Suppressor in Colorectal Cancer by Targeting the Nin One Binding Protein.

Nephroblastoma Overexpressed Protein (NOV) Enhances 5-Fu-mediated Inhibitory Effect of Colorectal Cancer Cell Proliferation Via JNK/AP-1/caspase-8/caspase-3 Pathway

Reduced NOV Expression Correlates with Disease Progression in Colorectal Cancer and is Associated with Survival, Invasion and Chemoresistance of Cancer Cells

Lnc00113 promotes triple‐negative breast cancer progression via the NOB‐1/MAPK signaling axis

Lentivirus-mediated Knockdown of Rhomboid Domain Containing 1 Inhibits Colorectal Cancer Cell Growth.

MicroRNA-326 Functions As a Tumor Suppressor in Glioma by Targeting the Nin One Binding Protein (NOB1)

LMNB1 deletion in ovarian cancer inhibits the proliferation and metastasis of tumor cells through PI3K/Akt pathway

OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer

Downregulated Mir-646 in Clear Cell Renal Carcinoma Correlated with Tumour Metastasis by Targeting the Nin One Binding Protein (NOB1)

NOB1 Gene As a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.

Pan-cancer exploration of PNO1: A prospective prognostic biomarker with ties to immune infiltration

Lentivirus-mediated Knockdown of CTDP1 Inhibits Lung Cancer Cell Growth in Vitro.

Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling Pathway

Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application

Oncogenic Role of NUPR1 in Ovarian Cancer